A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model-Reference-Cited by-同舟云学术

A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

Published:2012-09-30 Issue:10 Volume:18 Page:1570-1574
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kitazawa Takehisa,Igawa Tomoyuki,Sampei Zenjiro,Muto Atsushi,Kojima Tetsuo,Soeda Tetsuhiro,Yoshihashi Kazutaka,Okuyama-Nishida Yukiko,Saito Hiroyuki,Tsunoda Hiroyuki,Suzuki Tsukasa,Adachi Hideki,Miyazaki Taro,Ishii Shinya,Kamata-Sakurai Mika,Iida Takeo,Harada Aya,Esaki Keiko,Funaki Miho,Moriyama Chifumi,Tanaka Eriko,Kikuchi Yasufumi,Wakabayashi Tetsuya,Wada Manabu,Goto Masaaki,Toyoda Takeshi,Ueyama Atsunori,Suzuki Sachiyo,Haraya Kenta,Tachibana Tatsuhiko,Kawabe Yoshiki,Shima Midori,Yoshioka Akira,Hattori Kunihiro

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2942.pdf

Reference46 articles.

1. Fischer, K., Lewandowski, D., Marijke van den Berg, H. & Janssen, M.P. Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project. Haemophilia 18, e241–e246 (2012).

2. Oldenburg, J., El-Maarri, O. & Schwaab, R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 8 (suppl. 2), 23–29 (2002).

3. Berntorp, E. & Shapiro, A.D. Modern haemophilia care. Lancet 379, 1447–1456 (2012).

4. Shi, Q., Kuether, E.L., Schroeder, J.A., Fahs, S.A. & Montgomery, R.R. Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice. Haemophilia 18, 639–646 (2012).

5. Björkman, S. et al. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood 119, 612–618 (2012).

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies—generational enhancement;Journal of Thrombosis and Haemostasis;2024-02

2. A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state;Journal of Thrombosis and Haemostasis;2024-02

3. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15

4. Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks;Research and Practice in Thrombosis and Haemostasis;2024-01

5. NXT007-mediated hemostatic potential is suppressed by activated protein C-catalyzed inactivation of activated factor V;Research and Practice in Thrombosis and Haemostasis;2024-01